Neuronetics outlines $160M-$164M 2026 revenue outlook while targeting limited to no net cash utilization in H2

• CEO Daniel Reuvers said the company “continue[s] to execute against the profitability and operating cash goals we outlined earlier in the year,” and reported “total revenue for the quarter was approximately $42 million, up over 12% versus the

Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.